Pediatric Extrapulmonary Tuberculosis: Clinical Spectrum, Risk Factors and Diagnostic Challenges in a Low Prevalence

Begoña Santiago-García1, Daniel Blázquez-Gamero, Fernando Baquero-Artigao

  • 1From the *Hospital General Universitario Gregorio Marañón, Madrid, Spain; †Hospital General Universitario 12 de Octubre, Madrid, Spain; and ‡Hospital Universitario Infantil La Paz-Hospital Carlos III, Madrid, Spain.

Insights

Pediatric extrapulmonary tuberculosis (EPTB) in low-prevalence regions is associated with immigrant status, immune disorders, and drug resistance. Early diagnosis and screening are crucial for better outcomes in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Children face higher risks of tuberculosis (TB) dissemination and extrapulmonary disease (EPTB), leading to significant morbidity and long-term issues.
  • Limited research exists on the clinical spectrum and impact of pediatric EPTB, particularly in regions with low TB prevalence.

Purpose of the Study:

  • To analyze the epidemiology and clinical characteristics of pediatric EPTB in a low-prevalence region.
  • To compare diagnostic test performance between childhood extrapulmonary and pulmonary TB.
  • To identify factors associated with EPTB in children.

Main Methods:

  • Retrospective review of pediatric TB cases (<18 years) in the Madrid region (2005-2013).
  • Comparison of epidemiological and clinical data for EPTB versus pulmonary TB.
  • Multivariate logistic regression to determine factors linked to EPTB.

Main Results:

  • Pediatric EPTB accounted for 17.7% of cases, with lymphatic TB being most common.
  • EPTB cases showed lower source case identification, smaller tuberculin skin test indurations, but similar interferon-gamma-release assay sensitivity compared to pulmonary TB.
  • Children with EPTB had higher rates of bacteriologic confirmation, multidrug-resistant TB, and complications, and were associated with foreign origin, immune disorders, and drug resistance.

Conclusions:

  • Childhood EPTB in low-prevalence settings is associated with immigrant status, immune disorders, and drug resistance.
  • EPTB presents a high rate of complications in children.
  • Improved diagnostic tools and systematic TB screening in high-risk populations are essential.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
609
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
728
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349